Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B

TY - JOUR

T1 - Editorial

T2 - effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B

AU - Kim, Beom Kyung

AU - Kim, Seung Up

N1 - Funding Information: Declaration of potential personal interests: SU Kim served as a speakcer for DaeWoong Pharmaceuticals, SamJin Pharmaceuticals, Celltrion, Samil Pharmaceuticals, Dong-A ST, Echme, EchoSens, Bukwang Pharmaceuticals, Chong Kun Dang, Yuhan Pharmaceuticals, Gilead, Abbvie, MSD Korea, Bayer, Diagen, and Bristol-Myers Squibb and has received research fundings from Dong-A ST, Yuhan Pharmaceuticals, Chong Kun Dang, Hanmi Pharmaceuticals, and JW Pharmaceuticals. BK Kim served as a speakcer for Samil Pharmaceuticals, Dong-A ST, Yuhan Pharmaceuticals, Celltrion, Daewoong Pharmaceuticals, Bristol Myers Squibb, Chong Kun Dang, Bukwang Pharmaceuticals, Hanmi Pharmaceuticals, and Korea Otsuka Pharmaceuticals, and MSD Korea. These entities had no role in analysis, decision to publish, or preparation of the manuscript. Declaration of funding interests: None

PY - 2019/8

Y1 - 2019/8

UR - http://www.scopus.com/inward/record.url?scp=85069475295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069475295&partnerID=8YFLogxK

U2 - 10.1111/apt.15364

DO - 10.1111/apt.15364

M3 - Editorial

C2 - 31313364

AN - SCOPUS:85069475295

SN - 0269-2813

VL - 50

SP - 333

EP - 334

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 3

ER -